커넥티드 홈 헬스 시장 예측(-2034년) : 제품 유형, 유형, 구성 요소, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Connected Home Health Market is accounted for $455.9 billion in 2026 and is expected to reach $520.6 billion by 2034 growing at a CAGR of 1.6% during the forecast period. Connected home health is an integrated ecosystem of IoT-enabled medical devices, AI-powered remote monitoring platforms, telehealth applications, and digital health management services that collectively extend clinical-grade health monitoring, chronic disease management, and preventive wellness capabilities from traditional healthcare facilities into the home environment. These solutions include remote patient monitoring devices, smart vital sign monitors, connected medication management systems, AI-driven health hubs, virtual care platforms, and smart fall detection systems that communicate continuously with healthcare providers through cloud-based interoperability frameworks, serving chronically ill patients, post-surgical recovery cases, aging individuals, maternal and infant health cases, and preventive wellness consumers.

Market Dynamics:

Driver:

Personalized Home Monitoring Demand

Escalating consumer demand for healthcare experiences tailored to individual physiological baselines, chronic disease profiles, and lifestyle patterns is compelling device manufacturers, telehealth platforms, and health systems to invest in connected home health solutions that deliver genuinely personalized monitoring and intervention. AI-powered analytics platforms capable of interpreting longitudinal home biometric data to predict deterioration events, personalize medication adherence nudges, and adapt care protocols to individual response patterns are transforming connected home health from passive data collection into active, individualized health managements

Restraint:

Health Data Cybersecurity Obligations Escalate

Connected home health platforms generate continuous streams of highly sensitive personal health data including vital signs, medication adherence, sleep patterns, mobility data, and chronic disease biomarkers, creating substantial privacy, cybersecurity, and regulatory compliance obligations. HIPAA requirements for US-deployed platforms, GDPR for European deployments, and national health data sovereignty regulations across Asia Pacific impose complex, jurisdiction-specific compliance architectures that significantly increase platform development and operational costs.

Opportunity:

Elderly Assistive Care Devices Rapidly Expanding

Connected home health technologies designed to assist elderly individuals with limited mobility, patients with chronic neurological conditions, caregivers of individuals with cognitive impairment, and populations in rural or underserved communities lacking proximate healthcare access represent a rapidly expanding high-value opportunity. Voice-controlled health interfaces, AI fall detection systems, remote medication dispensing platforms, and smart vital sign monitors configured for users with limited technical literacy are unlocking demographic segments previously excluded from digital health adoption.

Threat:

Consumer Tech Giants Dominate Health

Apple, Amazon, Google, Samsung, and Microsoft are aggressively expanding their connected health ecosystems through device launches, health data platform investments, and healthcare provider partnerships that leverage existing consumer device footprints and brand trust at a scale specialist connected home health companies cannot replicate. Apple Health, Amazon Care, Google Health, and Samsung Health platforms create powerful data aggregation and ecosystem lock-in effects that position these technology giants to capture disproportionate long-term connected home health value. Their access to consumer behavioral data, dominant app distribution channels, and ability to bundle health monitoring within existing device categories creates asymmetric competitive advantages.

Covid-19 Impact:

The COVID-19 pandemic catalyzed transformational growth in connected home health by driving mass adoption of telehealth, demonstrating the clinical viability of remote patient monitoring for acute and chronic care management, and accelerating regulatory acceptance of home-based diagnostics and virtual care delivery. Hospital capacity pressures incentivized health systems to rapidly deploy remote monitoring programs for post-discharge patients. Post-pandemic health consumer behavior has permanently shifted toward home-based monitoring preferences, and expanded telehealth reimbursement frameworks established during the pandemic provide durable commercial infrastructure supporting sustained sector growth.

The remote patient monitoring (RPM) devices segment is expected to be the largest during the forecast period

The remote patient monitoring (RPM) devices segment is expected to account for the largest market share during the forecast period, due to the critical role these devices play in enabling continuous, clinician-supervised health surveillance outside of traditional care settings for high-risk patient populations managing chronic conditions including diabetes, heart failure, hypertension, and COPD. CMS reimbursement code expansion for remote physiological monitoring in the United States, combined with growing health system investment in hospital-at-home and early discharge programs, has created substantial institutional procurement demand. The breadth of clinical indications served, established device certification pathways, and strong health insurer support for RPM programs collectively underpin this segment's dominant market position.

The internet of medical things (IoMT) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the internet of medical things (IoMT) segment segment is predicted to witness the highest growth rate, driven by exponential growth of connected medical device deployments, cloud health data integration infrastructure, and AI-powered clinical decision support systems that collectively transform discrete health monitoring data streams into continuous, interoperable care intelligence networks. Falling IoMT connectivity component costs, expanding 5G network coverage enabling reliable real-time health data transmission, and deepening electronic health record interoperability standards are accelerating IoMT platform adoption across hospital systems, home health agencies, and consumer wellness markets globally, driving above-average growth across all key geographies.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by a highly developed telehealth reimbursement landscape, widespread consumer adoption of wearable health monitoring devices, and a large chronically ill and aging population creating structural demand for remote care solutions. The United States leads with CMS remote patient monitoring reimbursement codes, strong health system investment in hospital-at-home programs, and a mature digital health venture ecosystem. High consumer health technology spending and growing insurer coverage of connected monitoring devices reinforce the region's dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly aging populations in Japan, China, South Korea, and Australia, expanding mobile internet infrastructure enabling remote monitoring connectivity, and growing government investment in smart healthcare and aging-in-place programs. India's telemedicine adoption surge, China's internet hospital expansion, and Southeast Asia's mobile health growth are creating large-scale connected home health deployment environments. Rising middle-class health spending and growing insurer investment in preventive monitoring solutions amplify the region's growth momentum.

Key players in the market

Some of the key players in Connected Home Health Market include Philips Healthcare, Medtronic plc, Abbott Laboratories, Omron Healthcare Co., Ltd., Fitbit, Apple Inc., Samsung Electronics Co., Ltd., Withings S.A., ResMed Inc., Dexcom Inc., iRhythm Technologies Inc., BioTelemetry Inc., Teladoc Health Inc., Amazon Care, Best Buy Health, Honeywell Life Care Solutions, GE HealthCare Technologies Inc., and Garmin Ltd.

Key Developments:

In February 2026, Philips announced advancements in its remote patient monitoring solutions, integrating AI-driven analytics into home health devices. This update enhances early detection of chronic condition risks and supports its goal of improving the lives of 2.5 billion people annually by 2030.

In January 2026, Medtronic introduced new AI-powered diagnostic features in its connected care devices, including pulse oximeters and monitoring systems. These innovations allow real-time detection of cardiovascular and gastrointestinal conditions, strengthening its role in home-based preventive care.

In December 2025, Samsung showcased its expanded Samsung Health ecosystem, integrating virtual care, prescription management, and clinical data through its acquisition of Xealth. This move connects wellness tracking with healthcare delivery, positioning Samsung as a key player in connected home health.

Product Types Covered:

• Remote Patient Monitoring (RPM) Devices
• Smart Diagnostic & Vital Sign Monitors
• Connected Medication Management Systems
• AI-Powered Home Health Hubs
• Telehealth & Virtual Care Platforms
• Smart Fall Detection & Emergency Alert Devices
• Home-Based Chronic Disease Management Devices

Types Covered:

• Internet of Medical Things (IoMT)
• Artificial Intelligence & Predictive Analytics
• Wireless Communication (Bluetooth, Wi-Fi, Zigbee)
• Cloud-Based Health Data Management
• Voice & Natural Language Interface Technology
• Edge Computing for Real-Time Health Monitoring
• Blockchain for Health Data Security & Interoperability
• Spatial Audio & 3D Sound Processing

Components Covered:

• Hardware
• Software & Platforms
• Services

Applications Covered:

• Chronic Disease Management
• Post-Acute & Post-Surgical Recovery Monitoring
• Elderly & Aging-in-Place Care
• Maternal & Infant Health Monitoring
• Mental & Behavioral Health Support
• Preventive Health & Wellness Monitoring
• Industrial Plant & Factory Operators

End Users Covered:

• Patients & Individual Consumers
• Home Healthcare Agencies
• Hospitals & Health Systems
• Health Insurers & Payers
• Government & Public Health Agencies
• Elderly Care & Assisted Living Facilities

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Connected Home Health Market, By Product Type

• 5.1 Remote Patient Monitoring (RPM) Devices
• 5.2 Smart Diagnostic & Vital Sign Monitors
• 5.3 Connected Medication Management Systems
• 5.4 AI-Powered Home Health Hubs
• 5.5 Telehealth & Virtual Care Platforms
• 5.6 Smart Fall Detection & Emergency Alert Devices
• 5.7 Home-Based Chronic Disease Management Devices

6 Global Connected Home Health Market, By Type

• 6.1 Internet of Medical Things (IoMT)
• 6.2 Artificial Intelligence & Predictive Analytics
• 6.3 Wireless Communication (Bluetooth, Wi-Fi, Zigbee)
• 6.4 Cloud-Based Health Data Management
• 6.5 Voice & Natural Language Interface Technology
• 6.6 Edge Computing for Real-Time Health Monitoring
• 6.7 Blockchain for Health Data Security & Interoperability

7 Global Connected Home Health Market, By Component

• 7.1 Hardware
  • 7.1.1 Wearable Health Sensors & Monitors
  • 7.1.2 Home Diagnostic Devices (BP, Glucose, SpO2)
  • 7.1.3 Smart Gateways & Communication Hubs
• 7.2 Software & Platforms
  • 7.2.1 Remote Monitoring & Telehealth Applications
  • 7.2.2 AI-Powered Patient Analytics Dashboards
  • 7.2.3 EHR Integration & Interoperability Platforms
• 7.3 Services
  • 7.3.1 Device Installation & Patient Onboarding Services
  • 7.3.2 Remote Clinical Monitoring Services
  • 7.3.3 Data Management & Cybersecurity Services

8 Global Connected Home Health Market, By Application

• 8.1 Chronic Disease Management
• 8.2 Post-Acute & Post-Surgical Recovery Monitoring
• 8.3 Elderly & Aging-in-Place Care
• 8.4 Maternal & Infant Health Monitoring
• 8.5 Mental & Behavioral Health Support
• 8.6 Preventive Health & Wellness Monitoring

9 Global Connected Home Health Market, By End User

• 9.1 Patients & Individual Consumers
• 9.2 Home Healthcare Agencies
• 9.3 Hospitals & Health Systems
• 9.4 Health Insurers & Payers
• 9.5 Government & Public Health Agencies
• 9.6 Elderly Care & Assisted Living Facilities

10 Global Connected Home Health Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Philips Healthcare
• 13.2 Medtronic plc
• 13.3 Abbott Laboratories
• 13.4 Omron Healthcare Co., Ltd.
• 13.5 Fitbit
• 13.6 Apple Inc.
• 13.7 Samsung Electronics Co., Ltd.
• 13.8 Withings S.A.
• 13.9 ResMed Inc.
• 13.10 Dexcom Inc.
• 13.11 iRhythm Technologies Inc.
• 13.12 BioTelemetry Inc.
• 13.13 Teladoc Health Inc.
• 13.14 Amazon Care
• 13.15 Best Buy Health
• 13.16 Honeywell Life Care Solutions
• 13.17 GE HealthCare Technologies Inc.
• 13.18 Garmin Ltd.